Finding Pneumo
December 5, 2006
Today’s New York Times features efforts to introduce pneumococcal conjugate vaccine in developing countries, where it has the potential to combat life-threatening respiratory disease. Importantly, the article notes progress in putting together the pledges for a pilot application of the Advance Market Commitment to stimulate development and manufacture of pneumo vaccine that would be appropriate for use in African and Asian countries: $1 billion of the estimated $1.5 billion required, with the notable absence to date of pledges from the US and France.
You can skip to the end and leave a response. Pinging is currently not allowed.
We value frank and constructive exchanges and encourage you to use your real name in your comments.





Post a Comment